Project description
Big data aids in the transition from cancer patient to survivor
The transition from cancer patient to cancer survivor should be planned and coordinated to ensure patients receive high-quality, coordinated and personalised care. The EU-funded PERSIST project is developing a system that supports self-care and can identify outcomes that require professional intervention. Its system uses big data technology and novel analysis algorithms that can be easily integrated into electronic health records and other sources of clinical data. Overall, the project aims to improve the management, intervention and prevention strategies to reduce side effects and prevent secondary diseases. Its long-term goal is to reduce the socio-economic burden related to cancer survivors’ care by creating a dynamic decision support system and making maximum use of predictive models.
Objective
PERSIST aims at developing an open and interoperable ecosystem to improve the care of cancer survivors. The key results to be achieved by partners are: increased self-efficacy and satisfaction with care as well as reduced psychological stress for a better management of the consequences of the cancer treatment and the disease, resulting in an improvement in health and wellbeing and a faster integration into the labour market, where applicable, compared to usual care (KR1); increased effectiveness in cancer treatment and follow-up by providing prediction models from Big Data that will support decision-making and contribute to optimal treatment decisions with positive consequences in the QoL and the health status of survivors (KR2); and improved information and evidence to advance the efficacy of management, intervention and prevention policies/strategies in order to timely treat side effects and, if possible, avoid secondary diseases and fatal events. The long-term result will be to reduce the socio-economic burden related to cancer survivors’ care (KR3). The ecosystem proposed consists of a Big Data platform to be built on top of an open infrastructure from one of the partners and a mHealth application for patients. The main building blocks to be developed are a multimodal sensing network running on a smart phone that will collect relevant data regarding the wellbeing of the patient; predictive models from anonymised health data from thousands of breast and colorectal patients; and modules essential for the development of a decision support system, which will employ the predictive models mentioned. Furthermore, PERSIST will contribute to establish evidence on the use of liquid biopsy techniques to the follow-up of cancer patients treated with curative purposes. A pilot study involving 160 patients and 32 health care professionals will be decisive to establish a co-creation methodology ranging from the earlies phases of the project throughout its conclusion.
Fields of science
- natural sciencescomputer and information sciencesartificial intelligence
- natural sciencescomputer and information sciencesdata sciencebig data
- medical and health sciencesclinical medicineoncology
- natural sciencesbiological sciencesecologyecosystems
- social scienceseconomics and businessbusiness and managementemployment
Programme(s)
Funding Scheme
RIA - Research and Innovation actionCoordinator
36214 VIGO
Spain
See on map
Participants (17)
15703 Santiago De Compostela
See on map
Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.
36312 Vigo
See on map
Participation ended
28232 Madrid
See on map
Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.
Participation ended
29590 MALAGA
See on map
Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.
Participation ended
50197 Zaragoza
See on map
35430 İzmir
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
2000 Maribor
See on map
2000 Maribor
See on map
2800 Delemont
See on map
1586 RIGA
See on map
80024 Cardito
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
4000 Liege
See on map
1010 WIEN
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
4700314 Braga
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
1142 Sofia
See on map
28232 Madrid
See on map
Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.
29590 MALAGA
See on map